Discover 1,664 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,664
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
for
Fractures, Bone, Nonunion of Fracture, Fractures, Open,
Location: Jersey City NJ, Orlando FL
Sponsor: LifeNet Health
Sex: All
Age: 0+
Code: NCT04299022
Recruiting
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Location: Jersey City NJ, New York NY, The Bronx NY, Baltimore MD,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT05701358
Recruiting
Metformin in Patients With Fragile X
for
Fragile X Syndrome
Location: Stratford NJ
Sponsor: Rowan University
Sex: Male
Age: 18 - 50
Code: NCT04141163
Phase1, Phase2, Recruiting
Pedal Pump and Leg Lymphedema
for
Lymphedema
Location: Stratford NJ
Sponsor: Rowan University
Sex: All
Age: 55 - 70+
Code: NCT06235463
Recruiting
A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
for
Hereditary Angioedemas
Location: Belleville NJ, Saint Charles IL, Miami FL, Phoenix AZ,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT07001280
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of AZD0754 in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Philadelphia PA, New York NY, Hackensack NJ, Atlanta GA,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT06267729
Phase1, Phase2, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Philadelphia PA, Brooklyn NY, New York NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
for
GRIN-related Neurodevelopmental Disorder
Location: Philadelphia PA, Hackensack NJ, New York NY,
Sponsor: GRIN Therapeutics, Inc.
Sex: All
Age: 0 - 18
Code: NCT07224581
Phase3, Recruiting
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
for
Catheter-Related Infections
Location: Hackensack NJ, Wilmington DE, Birmingham AL,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 0 - 17
Code: NCT06714864
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Marlton NJ, Gaithersburg MD, North Canton OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951711
Phase3, Recruiting
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
for
Liver Cancer Adult, Liver Regeneration
Location: Englewood NJ
Sponsor: Englewood Hospital and Medical Center
Sex: All
Age: 18+
Code: NCT06681818
Recruiting
Featured
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New Brunswick NJ, New York NY, Toronto, Montreal,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase1, Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
for
Staphylococcus Aureus
Location: Jersey City NJ, Bethlehem PA, Ridgewood NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 55
Code: NCT06749457
Phase1, Phase2, Recruiting
Ultralow Dose PET Imaging of 18F-FDG Uptake
for
Healthy Volunteer, Cancer
Location: Englewood NJ
Sponsor: Akiva Mintz
Sex: All
Age: 18 - 70+
Code: NCT06956391
Phase2, Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Philadelphia PA, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase3, Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Philadelphia PA, New York NY, Hackensack NJ,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase1, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Philadelphia PA, Hackensack NJ, The Bronx NY,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma